about
Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD MouseThe antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes.Case-control association between CCT-associated variants and keratoconus in a Saudi Arabian populationmiRNA Profile in Three Different Normal Human Ocular Tissues by miRNA-Seq.Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cellsMolecular and Histopathological Changes Associated with Keratoconus.Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression.MicroRNA-183-5p Increases with Age in Bone-Derived Extracellular Vesicles, Suppresses Bone Marrow Stromal (Stem) Cell Proliferation, and Induces Stem Cell Senescence.A Common Variant in MIR182 Is Associated With Primary Open-Angle Glaucoma in the NEIGHBORHOOD Consortium.A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial Reagents.Protein kinase D1 deficiency promotes differentiation in epidermal keratinocytes.Screening of the Seed Region of MIR184 in Keratoconus Patients from Saudi Arabia.Regulation of the Glycerol Transporter, Aquaporin-3, by Histone Deacetylase-3 and p53 in Keratinocytes.Response to Letter to the Editor on "Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression".Aquaporin-3 re-expression induces differentiation in a phospholipase D2-dependent manner in aquaporin-3-knockout mouse keratinocytes.Differentially expressed microRNAs in the aqueous humor of patients with exfoliation glaucoma or primary open-angle glaucoma
P50
Q30363059-3FE2085A-CC33-44D3-9340-7AD6AF8634FBQ34785582-15694F48-C49C-454C-87C8-C874026B8012Q35710030-B6AE1026-50F8-47A7-91C0-347980BE9C13Q37126305-1076653F-D1DA-433D-9B62-EEB9FDA12B62Q37148646-96938B88-720E-4228-B133-81DE34A503A7Q37637768-453BF614-B98C-4A2A-BB9B-AFCA325228F2Q38780199-8C0C33CB-75FA-4846-9F3B-CC61AE8C329DQ38864355-A1BDB906-3646-4E5A-A68B-C28ED938CC18Q39477976-C9F6E6F1-BD84-4609-9ED3-45D71AA60AFBQ40437431-40D6C9C0-6009-4682-AD28-AE3F92CF2FDFQ41633583-7DAA8B8B-9249-4467-9EE0-2C6D6397C197Q42122913-F703B4F2-E174-405B-BE0A-F0128C9909B5Q48034366-5673DEEA-6362-477D-B0D8-C11256CE8C34Q50066573-A00A0A29-E702-43B8-BC9B-65975C7BBB01Q50633902-BADE719E-F71D-4EF3-9039-F60B776E7E24Q87689498-83418AB1-EF7F-454A-BCF5-C6496FBCFC54
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9294-9277
@en
name
Inas Helwa
@ast
Inas Helwa
@en
Inas Helwa
@es
Inas Helwa
@nl
type
label
Inas Helwa
@ast
Inas Helwa
@en
Inas Helwa
@es
Inas Helwa
@nl
prefLabel
Inas Helwa
@ast
Inas Helwa
@en
Inas Helwa
@es
Inas Helwa
@nl
P106
P1153
55996430700
P31
P496
0000-0002-9294-9277